Keyphrases
Acne
81%
Acne Treatment
16%
Acne Vulgaris
61%
Adapalene
22%
Adverse Events
30%
Apremilast
17%
Atopic Dermatitis
62%
Benzoyl Peroxide
44%
Betamethasone Dipropionate
26%
Calcipotriol
29%
Clindamycin Phosphate
26%
Clinical Trials
17%
Clobetasol Propionate
21%
Dermatologist
22%
Erythema
16%
Etanercept
16%
Fixed Combination
30%
Fixed-dose Combination
17%
Inflammatory Acne Vulgaris
21%
Investigator's Global Assessment
29%
Itch
20%
Lesion Count
22%
Lotion
49%
Moderate to Severe
46%
Moderate-to-severe Acne
34%
Moderate-to-severe Psoriasis
41%
Moisturizer
17%
Monotherapy
16%
Noninflammatory
22%
Once-daily
44%
Phase II Study
21%
Plaque Psoriasis
47%
Pruritus
21%
Psoriasis
94%
Psoriasis Disease
19%
Psoriasis Severity
20%
Psoriasis Treatment
21%
Psoriatic Arthritis
18%
Quality of Life
17%
Randomized Double-blind
22%
Rosaceae
17%
Skin Care
20%
Tazarotene
45%
Tolerability
62%
Topical Corticosteroids
22%
Topical Therapy
40%
Topical Treatment
20%
Treatment Efficacy
33%
Tretinoin
26%
Twice Daily
18%
Pharmacology, Toxicology and Pharmaceutical Science
Acne
94%
Acne Vulgaris
56%
Actinic Keratosis
10%
Adapalene
24%
Adverse Event
44%
Apremilast
14%
Atopic Dermatitis
63%
Benzoyl Peroxide
45%
Betamethasone Dipropionate
26%
Biological Product
13%
Bismuth Gallate
9%
Brodalumab
10%
Calcipotriol
28%
Ceramide
10%
Clindamycin
12%
Clindamycin Phosphate
27%
Clinical Study
9%
Clinical Trial
25%
Clocortolone Pivalate
10%
Combination Therapy
10%
Dapsone
10%
Disease
19%
Diseases
12%
Erythema
15%
Etanercept
9%
Infection
7%
Inflammation
18%
Interleukin 17
11%
Interleukin 23
9%
Microsphere
7%
Monotherapy
13%
Onychomycosis
8%
Placebo
19%
Pruritus
26%
Psoriasis
100%
Psoriasis Vulgaris
75%
Psoriatic Arthritis
8%
Retinoic Acid
23%
Roflumilast
12%
Rosacea
13%
Ruxolitinib
12%
Seborrheic Dermatitis
8%
Skin Disease
17%
Tapinarof
10%
Tazarotene
35%
Tinea pedis
8%
Tolerability
57%
Topical Agent
10%
Topical Corticosteroid
24%
Ulobetasol Propionate
14%
Medicine and Dentistry
Acne Vulgaris
46%
Acneiform Eruption
92%
Actinic Keratosis
10%
Adverse Event
21%
Androgen
7%
Apremilast
11%
Atopic Dermatitis
24%
Azelaic Acid
8%
Benzoyl Peroxide
12%
Betamethasone Dipropionate
17%
Biological Product
16%
Bismuth Subgallate
9%
Brodalumab
9%
Calcipotriol
18%
Ceramide
10%
Clinical Trial
14%
Clinician
12%
Dermatology
16%
Dermatosis
12%
Disease
22%
Diseases
10%
Erythema
11%
Etanercept
9%
Interleukin 17
13%
Interleukin 23
7%
Minocycline
7%
Monotherapy
9%
Onychomycosis
9%
Pathophysiology
9%
Patient Compliance
8%
Patient-Reported Outcome
12%
Pediatrics
10%
Placebo
10%
Pruritus
21%
Psoriasis
85%
Psoriasis Vulgaris
52%
Psoriatic Arthritis
10%
Quality of Life
19%
Rhinophyma
19%
Roflumilast
10%
Scalp
12%
Scalp Psoriasis
10%
Seborrheic Dermatitis
9%
Serositis
10%
Skin Care
9%
Tazarotene
19%
Topical Corticosteroid
13%
Topical Treatment
23%
Tretinoin
11%
Ulobetasol Propionate
8%